Malignant tumor of prostate (disorder)

Circulating Cancer Cells

Year Started: 2000

Blood products from patients with primary tumour site in the prostate and circulating cancer cells in the bloodstream

Access:
Open in response to specific calls
Type:
Disease specific
Status:
In progress
Collection point:
Post-diagnosis
Consent restrictions:
No restrictions


Data not recorded

Adult (> 40 years)

1 - 10 donors

Material Type Preservation Type % of Sample Set Macroscopic Assessment
Peripheral blood cells Liquid nitrogen 11 - 25% Not applicable
Plasma -60 °C to -85 °C 11 - 25% Not applicable
Serum -60 °C to -85 °C 26 - 50% Not applicable

Malignant tumor of prostate (disorder)

ProCAID

Year Started: 2014

Serum, plasma and buffy coat isolated from whole blood at each treatment cycle. FFPE blocks also collected.

Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Collection point:
Multiple points in patient pathway
Consent restrictions:
No restrictions


Male

Adult (> 40 years)

101 - 500 donors

Material Type Preservation Type % of Sample Set Macroscopic Assessment
Peripheral blood cells -60 °C to -85 °C 26 - 50% Not applicable
Plasma -60 °C to -85 °C 26 - 50% Not applicable
Serum -60 °C to -85 °C 26 - 50% Not applicable
Tissue Paraffin 0 - 10% Not applicable